Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Unknown 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 38INDUSTRY 25OTHER_GOV 3NETWORK 2

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Uterine Neoplasms 1Triple Negative Breast Neoplasms 1Esophageal Neoplasms 1

Interventions

Cisplatin 48Capecitabine 41Gemcitabine 33apatinib 32Oxaliplatin 32Cyclophosphamide 31Radiotherapy 29Paclitaxel 29Carboplatin 29tislelizumab 27Irinotecan 27Drug Therapy 27Fluorouracil 26Docetaxel 26Bevacizumab 23fludarabine 18Nivolumab 17pembrolizumab 16Surgical Procedures, Operative 16Exercise 16Metformin 15S 1 (combination) 14camrelizumab 13Radiation 13Pemetrexed 13Control Groups 12anlotinib 11Leucovorin 11Vinorelbine 10Standard of Care 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER_GOV × Interventional × CP protocol × Clear all
NCT03168880 2025-04-09

TNBC

Tata Memorial Hospital

Phase 3 Active not recruiting
720 enrolled
Breast

Triple Negative Breast Neoplasms

NCT02924909 2018-03-20

QUIMERA

Instituto Nacional de Cancer, Brazil

Phase 2 Unknown
50 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT00147680 2012-02-02

Uterine Papillary Serous Cancer (UPSC) Trial

Queensland Centre for Gynaecological Cancer

Phase 2 Completed
30 enrolled
Gynecologic

Uterine Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡